In focus · trending topic

CRISPR Therapeutics

9 stories · following the connections

CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies

By Nasdaq OMXAug 22, 2017, 11:30 AM UTC

CRISPR Therapeutics Announces Exclusive License of Lipid Nanoparticle Technologies Developed at MIT

By Nasdaq OMXMay 8, 2017, 12:00 PM UTC

CRISPR Therapeutics to Present at the 16th Annual Needham Healthcare Conference

By Nasdaq OMXMar 30, 2017, 12:01 PM UTC

CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing

By Nasdaq OMXMar 28, 2017, 12:01 PM UTC

CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing

By Nasdaq OMXMar 28, 2017, 12:01 PM UTC

CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte

By Nasdaq OMXMar 14, 2017, 11:00 AM UTC

CRISPR Therapeutics to Present at the Annual Barclays Global Healthcare Conference

By Nasdaq OMXMar 2, 2017, 9:30 PM UTC

CRISPR Therapeutics Announces the Appointment of Jon Terrett, Ph.D. to Head of Immuno-Oncology Research and Translation

By Nasdaq OMXFeb 28, 2017, 1:01 PM UTC